Revenue built on device sales is secondary, investors say
September 20, 2026  |  Log in   |  Read online   |  Manage your subscription  
PitchBook, a Morningstar company
The Weekend Pitch
Presented by Arcesium
Sponsored by Arcesium
Wearables investors are betting on your data, not your device
leah-hodgson-photo.jpg
By Leah Hodgson
Deputy Editor, European Private Markets
Wearables.png

Drew Sanders/PitchBook

Just over a decade ago, one in eight US adults owned a wearable. Today, it’s closer to one in two, and most of them never take it off.

Millions of people use the devices to monitor everything from sleep quality to heart rate variability. Investors are about to take its pulse: the sector faces its biggest test since Fitbit’s 2015 IPO, as smart ring maker Oura prepares to go public.

In 2015, the Finnish-born company sold its first sleep tracker through a Kickstarter campaign that raised $650,000. Now headquartered in both San Francisco and Oulu, Finland, it’s gearing up for a listing as early as this month that could value it at up to $16 billion, nearly four times what Fitbit achieved.

In its S-1, Oura describes itself as “an always-on health intelligence platform,” emphasizing its data and intelligence capabilities and its “highly retentive” subscription model.

“Oura is the first real public test of this newer wearable category at scale, so everyone’s watching,” said Mike Collett, founder and managing partner of Promus Ventures, which invested in fitness wearable Whoop. “If it prices well, it reprices the whole space and pulls the next wave of wearable companies toward the public markets.”

Investment in wearables and quantified self startups has reached $4.1 billion this year, according to PitchBook data, with several large deals closing, including smart health tracker Whoop’s $575 million Series G.

The sector has been helped by lower hardware costs, but the real value, according to Shapiro, lies beyond the device.

“Hardware is the distribution channel and potentially a sensing moat, but it’s the recurring intelligence layer, and subscription multiple that goes with it, that will determine long-term value,” he said.

Read more
A MESSAGE FROM ARCESIUM
See what’s possible with cross-fund performance analytics from Aquata®

As private markets and private credit portfolios grow, so do the complexities of managing performance and fee calculations. It’s why many firms are outgrowing traditional models.

With cross-fund performance analytics from Aquata, firms can scale up with a solution that delivers a single calculation engine and one governed data source. See for yourself with an interactive product tour, where you’ll discover how it empowers firms to:

  • Consistently calculate and roll up performance
  • Access full data lineage with a built-in audit trail
  • Get model fees and waterfalls without spreadsheets or engineering tickets
  • Generate LP-ready reporting

Ready to explore Aquata?

Take the tour

Arcesiumimage

TRIVIA
Hull City v Chelsea - Emirates FA Cup Fourth Round

Chelsea Football Club via Getty Images

Clearlake gained full control of Chelsea FC last week with a £950 million purchase of stakes from Mark Walter and Todd Boehly. Thinking back to when they acquired the stake, which global event created the opportunity for Walter and Boehly to buy into the club in the first place?

A) The COVID-19 pandemic
B) Russia’s invasion of Ukraine in 2022
C) The death of Queen Elizabeth II
D) Brexit


ICYMI

PE-Fundraising_012626_Header Image.png

Four charts: Private capital fundraising remains bleak through H1 2026

Fundraising is on pace to decline for the fifth consecutive year, with private credit the sole bright spot, PitchBook data shows.

Middle Market_header.png

Middle-market PE firms move down market in search of value

Deals between $25 million and $100 million increased in value by 70% in Q2, while activity in every other size bucket contracted or stalled.

DARIO

AI’s safety slowdown spooks the market, delays IPOs, and hands incumbents more room to run